Literature DB >> 16510042

The good fat hormone: adiponectin and cardiovascular disease.

Dat Do1, Jorge Alvarez, Elaine Chiquette, Robert Chilton.   

Abstract

New treatments for heart disease continue to be of paramount importance. The newest pandemic facing us is the rise of obesity and diabetes. One new area of research in the field of metabolism is the hormone adiponectin, which is secreted by fat cells. For the most part, this compound seems more likely to be a part of basic science-oriented research; however, it deserves a much closer look. Many compounds such as high-density lipoprotein and others at first were simply markers of disease but later found to be much more important. During this short review, research from basic science to clinical cardiovascular events is discussed in relation to adiponectin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510042     DOI: 10.1007/s11883-006-0045-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  46 in total

Review 1.  Role of CD36 in membrane transport of long-chain fatty acids.

Authors:  Azeddine Ibrahimi; Nada A Abumrad
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-03       Impact factor: 4.294

2.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yoshihisa Okamoto; Shinji Kihara; Noriyuki Ouchi; Makoto Nishida; Yukio Arita; Masahiro Kumada; Koji Ohashi; Naohiko Sakai; Iichiro Shimomura; Hideki Kobayashi; Naoki Terasaka; Toshimori Inaba; Tohru Funahashi; Yuji Matsuzawa
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

Review 5.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

Review 6.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

7.  Adiponectin-mediated modulation of hypertrophic signals in the heart.

Authors:  Rei Shibata; Noriyuki Ouchi; Masahiro Ito; Shinji Kihara; Ichiro Shiojima; David R Pimentel; Masahiro Kumada; Kaori Sato; Stephan Schiekofer; Koji Ohashi; Tohru Funahashi; Wilson S Colucci; Kenneth Walsh
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

8.  The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

Authors:  M Bensaid; M Gary-Bobo; A Esclangon; J P Maffrand; G Le Fur; F Oury-Donat; P Soubrié
Journal:  Mol Pharmacol       Date:  2003-04       Impact factor: 4.436

9.  Hypoadiponectinemia is closely linked to endothelial dysfunction in man.

Authors:  Michio Shimabukuro; Namio Higa; Tomohiro Asahi; Yoshito Oshiro; Nobuyuki Takasu; Tatsuya Tagawa; Shinichiro Ueda; Iichiro Shimomura; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

10.  Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

Authors:  Hui Chen; Monica Montagnani; Tohru Funahashi; Iichiro Shimomura; Michael J Quon
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

View more
  3 in total

Review 1.  Cardiac remodeling in obesity.

Authors:  E Dale Abel; Sheldon E Litwin; Gary Sweeney
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 2.  Cardiovascular dysfunction in obesity and new diagnostic imaging techniques: the role of noninvasive image methods.

Authors:  José Augusto A Barbosa; Alexandre B Rodrigues; Cleonice Carvalho C Mota; Márcia M Barbosa; Ana C Simões e Silva
Journal:  Vasc Health Risk Manag       Date:  2011-05-10

3.  iTRAQ-Based Quantitative Proteomics Analysis of the Protective Effect of Yinchenwuling Powder on Hyperlipidemic Rats.

Authors:  Zheyu Zhang; Wenbo Wang; Ling Jin; Xin Cao; Gonghui Jian; Ning Wu; Xia Xu; Ye Yao; Dongsheng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.